Hematology/Oncology Update from NEJM

The New England Journal of Medicine
View in browser
Advertisement
User Icon  Mufhandu Muvuledzi
Subscribe
NEJM Logo
Hematology/Oncology Update
March 2025
Original Research
Original Article  |  Feb 27, 2025  |  CME  |  Video
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
S. Gupta and Others
Blinatumomab in B-Cell Acute Lymphoblastic Leukemia
Quick Take
Blinatumomab in B-Cell Acute Lymphoblastic Leukemia
Original Article  |  Feb 20, 2025  |  Video
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
J.R. Brown and Others
Acalabrutinib Combinations in Chronic Lymphocytic Leukemia
Quick Take
Acalabrutinib Combinations in Chronic Lymphocytic Leukemia
Original Article  |  Feb 13, 2025  |  CME  |  Video
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
J.A. Chan and Others
Editorial NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors
Cabozantinib for Advanced Neuroendocrine Tumors
Quick Take
Cabozantinib for Advanced Neuroendocrine Tumors
Original Article  |  Feb 12, 2025
Brief Report: VITT-like Monoclonal Gammopathy of Thrombotic Significance
J.J. Wang and Others
Original Article  |  Feb 13, 2025
Brief Report: CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
S.J. Harrison and Others
Original Article  |  Feb 06, 2025
Brief Report: CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53
K. Perica and Others
Original Article  |  Feb 06, 2025
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
A.M. Schram and Others
Original Article  |  Feb 05, 2025
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
M. Goyal and Others
Original Article  |  Feb 05, 2025
Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
M. Psychogios and Others
Correspondence  |  Feb 20, 2025
The Duration of Immunotherapy for Mismatch Repair–Deficient Cancers
Correspondence  |  Feb 13, 2025
Maternal Anti-PF4 Antibodies as Cause of Neonatal Stroke
Correspondence  |  Feb 06, 2025
Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman's Disease
 
Clinical Practice and Review
Review Article  |  Feb 06, 2025  |  CME
Hemophagocytic Lymphohistiocytosis
J.-I. Henter
Case Records of the Massachusetts General Hospital  |  Feb 27, 2025  |  CME
Case 7-2025: A 65-Year-Old Woman with Weakness, Back Pain, and Pancytopenia
R.K. Leaf and Others
 
Multimedia
Multimedia 1
Images in Clinical Medicine
Laryngeal Involvement in Disseminated Cryptococcosis
Multimedia 2
Images in Clinical Medicine
Tumoral Melanosis
 
Perspective and Commentary
Perspective  |  Feb 27, 2025
One Size Fits … Some
D. Chammas
Perspective  |  Feb 26, 2025
What's Next for Nicotine? The Coming Legal and Political Battles over an FDA Proposal
P.J. Zettler, T.L. Wagener, and M.L. Berman
Non-Sub version: Notable Articles of 2024
Perspective  |  Feb 20, 2025
Resilience and the Fallacy of "One Size Fits All"
A.R. Rosenberg
Perspective  |  Feb 20, 2025  |  Audio
Out of Pocket Getting Out of Hand — Reducing the Financial Toxicity of Rapidly Approved Drugs
P.A. Ubel, A. Grouls, and A.S. Kesselheim
Perspective  |  Feb 13, 2025
My Mother's Choices
H. Kirsch
Editorial  |  Feb 13, 2025  |  FREE  |  Audio
NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors
E.J. Rubin, O.O. Yeku, and S. Morrissey
Editorial  |  Feb 05, 2025
Medium- and Distal-Vessel Occlusion — The Limit of Thrombectomy?
J. Mocco
Perspective  |  Feb 06, 2025  |  Audio
Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries
J.S. Ross
 
Keep up with NEJM AI
NEJM AI This Week
A weekly email newsletter featuring the latest research and applications of artificial intelligence to clinical medicine, including information about the latest issue of NEJM AI.
Sign Up Now  Arrow
Subscribe to the New England Journal of Medicine
Get full access to the information you trust to stay informed and improve patient care. Your subscription includes 52 weeks of NEJM.org access, 50 free article views from the NEJM Archive (1812-1989), and free access to all NEJM Weekly CME activities.
Subscribe Today  Arrow
Home Promo Ad
NEJM Career Center
PHYSICIAN JOBS
Hematology / Oncology
Malignant Hematology - Physician Scientist Opportunity
Loma Linda, California
Hematology / Oncology
BC/BE Hem/Onc for Gorgeous Northern ID Cancer Center - We'll Buy Your Hunting/Fishing License!
Lewiston, Idaho
Looking for a new practice opportunity? View these jobs and other listings at
NEJM CareerCenter
FOLLOW US
Facebook Twitter Instagram LinkedIn YouTube
This email was sent to mufhandu.o.itsol@blogger.com
To stop receiving these emails, unsubscribe from NEJM Hematology/Oncology Alert. Sign in to update preferences or sign up for additional email alerts. Did this email get forwarded to you? Sign up here.
To ensure you always receive NEJM Hematology/Oncology Alert, add alerts@n.nejm.org to your Contacts or Address Book.
The New England Journal of Medicine • 860 Winter Street • Waltham, MA 02451USA
Copyright © 2025 Massachusetts Medical Society. All rights reserved.
NEJM Group

Post a Comment

0 Comments